- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
- 40FR12B Initial registration of securities (Canada)
- 99.1 EX-99.1
- 99.2 EX-99.2
- 99.3 EX-99.3
- 99.4 EX-99.4
- 99.5 EX-99.5
- 99.6 EX-99.6
- 99.7 EX-99.7
- 99.8 EX-99.8
- 99.9 EX-99.9
- 99.10 EX-99.10
- 99.11 EX-99.11
- 99.12 EX-99.12
- 99.13 EX-99.13
- 99.14 EX-99.14
- 99.15 EX-99.15
- 99.16 EX-99.16
- 99.17 EX-99.17
- 99.18 EX-99.18
- 99.19 EX-99.19
- 99.21 EX-99.21
- 99.22 EX-99.22
- 99.23 EX-99.23
- 99.24 EX-99.24
- 99.25 EX-99.25
- 99.26 EX-99.26
- 99.27 EX-99.27
- 99.28 EX-99.28
- 99.29 EX-99.29
- 99.31 EX-99.31
- 99.32 EX-99.32
- 99.33 EX-99.33
- 99.34 EX-99.34
- 99.35 EX-99.35
- 99.36 EX-99.36
- 99.37 EX-99.37
- 99.38 EX-99.38
- 99.39 EX-99.39
- 99.40 EX-99.40
- 99.41 EX-99.41
- 99.42 EX-99.42
- 99.43 EX-99.43
- 99.44 EX-99.44
- 99.45 EX-99.45
- 99.46 EX-99.46
- 99.47 EX-99.47
- 99.48 EX-99.48
- 99.49 EX-99.49
- 99.50 EX-99.50
- 99.51 EX-99.51
- 99.52 EX-99.52
- 99.53 EX-99.53
- 99.54 EX-99.54
- 99.55 EX-99.55
- 99.56 EX-99.56
- 99.57 EX-99.57
- 99.58 EX-99.58
- 99.59 EX-99.59
- 99.60 EX-99.60
- 99.61 EX-99.61
- 99.62 EX-99.62
- 99.63 EX-99.63
- 99.64 EX-99.64
- 99.65 EX-99.65
- 99.66 EX-99.66
- 99.67 EX-99.67
- 99.68 EX-99.68
- 99.69 EX-99.69
- 99.70 EX-99.70
- 99.71 EX-99.71
- 99.72 EX-99.72
- 99.73 EX-99.73
- 99.74 EX-99.74
- 99.75 EX-99.75
- 99.76 EX-99.76
- 99.77 EX-99.77
- 99.78 EX-99.78
- 99.79 EX-99.79
- 99.80 EX-99.80
- 99.81 EX-99.81
- 99.82 EX-99.82
- 99.83 EX-99.83
- 99.84 EX-99.84
- 99.85 EX-99.85
- 99.86 EX-99.86
- 99.87 EX-99.87
- 99.88 EX-99.88
- 99.89 EX-99.89
- 99.90 EX-99.90
- 99.91 EX-99.91
- 99.92 EX-99.92
- 99.93 EX-99.93
- 99.94 EX-99.94
- 99.95 EX-99.95
- 99.96 EX-99.96
- 99.97 EX-99.97
- 99.98 EX-99.98
- 99.99 EX-99.99
- 99.100 EX-99.100
- 99.101 EX-99.101
- 99.102 EX-99.102
- 99.103 EX-99.103
- 99.104 EX-99.104
- 99.105 EX-99.105
- 99.106 EX-99.106
- 99.108 EX-99.108
- 99.109 EX-99.109
- 99.110 EX-99.110
- 99.111 EX-99.111
- 99.112 EX-99.112
- 99.113 EX-99.113
- 99.114 EX-99.114
- 99.115 EX-99.115
- 99.116 EX-99.116
- 99.117 EX-99.117
- 99.118 EX-99.118
- 99.119 EX-99.119
- 99.120 EX-99.120
- 99.121 EX-99.121
- 99.122 EX-99.122
- 99.123 EX-99.123
- 99.124 EX-99.124
- 99.125 EX-99.125
- 99.126 EX-99.126
- 99.127 EX-99.127
- 99.128 EX-99.128
- 99.129 EX-99.129
- 99.130 EX-99.130
Exhibit 99.104
VIA SEDAR
May 10, 2018
Alberta Securities Commission
Autorité des marchés financiers (Québec)
British Columbia Securities Commission
Manitoba Securities Commission
New Brunswick Securities Commission
Service Newfoundland and Labrador
Nova Scotia Securities Commission
Ontario Securities Commission
Prince Edward Island Securities Office
Saskatchewan Financial Services Commission
RE : Report of Voting Results pursuant to Section 11.3 of National Instrument 51-102 Continuous Disclosure Obligations (« NI 51-102 »)
Following the Annual and Special Meeting of Shareholders of Prometic Life Sciences Inc. (the “Corporation”) held on May 9, 2018 (the “Meeting”), and in accordance with section 11.3 of NI 51-102, continuous disclosure obligations, we hereby advise you of the matters voted upon at the Meeting and the voting results, the whole as detailed in the Management Information Circular of the Corporation dated March 22, 2018 (the “Circular”). According to the scrutineers’ report, the shareholders present at the meeting, in person or by proxy, represented 322,348,643 Common Shares, or 45.25% of the 712,329,990 shares outstanding on March 29, 2018, the record date for the Meeting.
Election of Directors of the Corporation
The ten (10) nominees for Directors who were proposed by management of the Corporation were elected:
Name of Nominee | For | Against | Withheld | |||||||||||||||||
Votes | % | Votes | % | Votes | % | |||||||||||||||
Simon Best | 245,117,480 | 87.25 | n/a | n/a | 35,813,127 | 12.75 | ||||||||||||||
Stefan Clulow | 265,268,033 | 94.42 | n/a | n/a | 15,662,574 | 5.58 | ||||||||||||||
Kenneth Galbraith | 254,986,445 | 90.76 | n/a | n/a | 25,944,162 | 9.24 | ||||||||||||||
David John Jeans | 240,571,326 | 85.63 | n/a | n/a | 40,359,281 | 14.37 | ||||||||||||||
Charles Kenworthy | 225,667,717 | 80.33 | n/a | n/a | 55,262,890 | 19.67 | ||||||||||||||
Pierre Laurin | 253,205,439 | 90.13 | n/a | n/a | 27,725,168 | 9.87 | ||||||||||||||
Louise Ménard | 200,382,357 | 71.33 | n/a | n/a | 80,548,249 | 28.67 | ||||||||||||||
Paul Mesburis | 257,704,340 | 91.73 | n/a | n/a | 23,226,267 | 8.27 | ||||||||||||||
Kory Sorenson | 263,609,498 | 93.83 | n/a | n/a | 17,321,109 | 6.17 | ||||||||||||||
Bruce Wendel | 267,724,411 | 95.30 | n/a | n/a | 13,206,196 | 4.70 |
Appointment of Auditors
Ernst & Young LLP were appointed auditors of the Corporation to hold office until the next annual meeting of shareholders, and the board of directors was authorized to fix the auditors’ remuneration.
For | Against | Withheld | ||||||||
Votes | % | Votes | % | Votes | % | |||||
303,479,209 | 97.94 | n/a | n/a | 6,373,800 | 2.06 |
Increase of the maximum number of Common Shares reserved for issuance under the amended and restated Stock Option Plan
The increase of the maximum number of Common Shares reserved for issuance under the amended and restated Stock Option Plan was approved.
For | Against | Withheld | ||||||||
Votes | % | Votes | % | Votes | % | |||||
219,201,374 | 78.03 | 61,729,232 | 21.97 | n/a | n/a |
Increase of the maximum number of Common Shares reserved for issuance under the amended and restated Restricted Share Unit Plan
The increase of the maximum number of Common Shares reserved for issuance under the amended and restated Restricted Share Unit Plan was approved.
For | Against | Withheld | ||||||||
Votes | % | Votes | % | Votes | % | |||||
221,107,388 | 78.71 | 59,823,218 | 21.29 | n/a | n/a |
Consolidation of the Outstanding Common Shares of the Corporation
The amendment to the articles of the Corporation to effect a consolidation of all of the issued and outstanding common shares was approved, such that the trading price of the post-consolidation common shares is at a minimum of US$10 per post-consolidation common shares calculated based on the 5-day VWAP volume weighted average trading price of the common shares (or such consolidation ratio that will permit the Corporation to meet its objectives with respect to a potential secondary listing on the Nasdaq Stock Exchange), effective as at the discretion the Board.
For | Against | Withheld | ||||||||
Votes | % | Votes | % | Votes | % | |||||
237,858,484 | 84.67 | 43,072,123 | 15.33 | n/a | n/a |
Reconfirmation and Approval of the Fourth Amended and Restated Shareholder Rights Plan Agreement
The Fourth Amended and Restated Shareholder Rights Plan Agreement to be effective until the termination of the annual meeting of the shareholders of the Corporation in the year 2021 was reconfirmed and approved.
For | Against | Withheld | ||||||||
Votes | % | Votes | % | Votes | % | |||||
230,912,394 | 82.20 | 50,018,213 | 17.80 | n/a | n/a |
Reconfirmation and Approval of the the Fourth Amended and Restated Spin-Off Shareholder Rights Plan Agreement
The Fourth Amended and Restated Spin-Off Shareholder Rights Plan Agreement to be effective until the termination of the annual meeting of the shareholders of the Corporation in the year 2021 was reconfirmed and approved.
For | Against | Withheld | ||||||||
Votes | % | Votes | % | Votes | % | |||||
232,665,856 | 82.82 | 48,264,751 | 17.18 | n/a | n/a |
PROMETIC LIFE SCIENCES INC. |
(s) Patrick Sartore |
Patrick Sartore |
Corporate Secretary |